Navigation Links
Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period
Date:7/17/2008

EF="http://www.hologic.com" target="_new">http://www.hologic.com and the website maintained by the SEC at http://www.sec.gov. In addition, stockholders are able to obtain a free copy of these documents by contacting Hologic or Third Wave.

Information Concerning Forward-Looking Statements

Information set forth in this communication contains forward-looking statements, which involve a number of risks and uncertainties. Such forward-looking statements include, but are not limited to, statements about the timing of the completion of the transaction, Hologic's and Third Wave's plans, objectives, expectations and intentions and other statements that are not historical facts. Hologic and Third Wave caution readers that any forward-looking information is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking information.

Risks and uncertainties include, among others: the risk that the businesses will not be integrated successfully; the transaction may involve unexpected costs or unexpected liabilities; the risk that the cost savings and any other synergies from the transaction may not be fully realized or may take longer to realize than expected; disruption from the transaction making it more difficult to maintain relationships with customers, employees or suppliers; competition and its effect on pricing, spending, third-party relationships and revenues; the risk of Third Wave's products not obtaining regulatory approval or significant delays in obtaining such approval; the need to develop new products and adapt to significant technological change; implementation of strategies for improving internal growth; use and protection of intellectual property; dependence on customers' capital spending policies and government funding policies, including third-party reimbursement; realization of potential future savings from new productivity ini
'/>"/>

SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens
2. Hologic, Inc. to Release First Quarter Fiscal 2008 Operating Results Thursday, January 31st Before Market Opens
3. FDA Accepts Immucors Response to Warning Letter
4. FDA Accepts Zingo(TM) Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults
5. U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile
6. Imaging Diagnostic Systems Accepts Resignations of Outside Directors
7. EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes
8. FDA Accepts Ranexa(R) sNDA and NDA for Filing
9. FDA Accepts Sucampos sNDA for Lubiprostone (8 mcg) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)
10. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
11. Warburg Pincus Acquires 5.4% of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2008)...ps visitors to electronica 2008 in Munich and cove...ronica information available on the visitor hotlin...ing a trip, online registration benefits, a summar...des an extensive list of web links to travel, hote... Munich, Germany (PRWEB) September 6, 2008 -- ...
(Date:9/5/2008)...er nanowires to nanoelectrodes. Talk about fine wo...hat,s why a new electroplating process that simult...atterned electrodes was selected for a 2008 Nano 5...s many difficulties. , "All of the electroplatin... National Laboratories researcher at the Center fo...
(Date:9/5/2008)...ll/ -- Gen-Probe Incorporated,(Nasdaq: GPRO ) ann...Morgan,Stanley Global Healthcare Unplugged Confere... 2:45 p.m. Eastern Time. The presentation is sched...h a link on the investors,section of Gen-Probe,s w...will be available for 30 days following the event....
(Date:9/5/2008)...-, - Exchange: OTCBB, Immureboost I...to,Fountain Healthy Aging Inc., Fountain Healthy ...approval of the name change by the Board of Direct... Tony Jimenez said a name change "was appropriate ...siness plan ", Dr Jimenez went on to say that; "F...
Breaking Biology Technology:Free White Paper Now Available: How to get the most from your visit to electronica 2008 in Munich 2Free White Paper Now Available: How to get the most from your visit to electronica 2008 in Munich 3Parallel 'nano-soldering' technique chosen for year's top-50 by Nanotech Briefs 2Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference 2Immureboost Inc Announces a Change of Name to Fountain Healthy Aging Inc 2
... Large scale gene expression studies , ...hesize and then , purify high quality..., MEGAscript RNAi Kit includes reagen...ean up, it is not optimized for clean up in a 96 w...oughput applications, we recommend , ...
...mpatible with GeneChip , analys... 100 , ng RNA in a single round... ArrayScript engineered M-MLV RT, e...of full- length cDNA , cR...cript, the best in vitro transcription technology ...
...performing several RNAi , scree...ied , five procedures that sign... screen results. , Min... siRNA concentration Use , ..., Correct for cell number N...
... , , Convenient format - pr...d , Optimized for highest yield of... , Complete with SUPERaseIn RNase in... , Ideal for microinjection, in vitro ... The mMESSAGE mMACHINE High Yiel...
Other Biology Technology:RNAi for High Throughput Analysis 2RNA Amplification Just Got Better: MessageAmp II 2RNA Amplification Just Got Better: MessageAmp II 3RNA Amplification Just Got Better: MessageAmp II 4RNA Amplification Just Got Better: MessageAmp II 5Recommendations for Successful siRNA Library Screens 2Recommendations for Successful siRNA Library Screens 3Recommendations for Successful siRNA Library Screens 4Recommendations for Successful siRNA Library Screens 5Recommendations for Successful siRNA Library Screens 6Recommendations for Successful siRNA Library Screens 7Recommendations for Successful siRNA Library Screens 8Rapidly Synthesize Large Amounts of Capped RNA 2Rapidly Synthesize Large Amounts of Capped RNA 3Rapidly Synthesize Large Amounts of Capped RNA 4
(Date:9/5/2008)...acksburg, Va. -- Innovative work on a new type of ...assistant professor of mechanical engineering at V...y Early Career Development (CAREER) award of $400,...e development of specific models and experiments t... with a stent that has a unique type of in situ po...
(Date:9/5/2008)...ility to echolocate may have evolved more than onc...een Mary, University of London scientists. , Spe...all group together in the evolutionary tree of lif...g cousins, the fruit bats. This has raised the que...more than once, or whether the fruit bats somehow ...
(Date:9/5/2008)...n fatty acid synthase is one of the most complex m...also a promising target for the development of ant...of metabolic disorders. Now researchers at ETH Zur...alian fatty acid synthase. Their results have just... of fatty acids is a central cellular process that...
(Date:9/4/2008)...rg, 5 September 2008 Even scientists define ,a ge...ise that the media also have various ways of frami... appearing in the October 2008 issue of EMBO repo...he analysis of 300 articles in British and Norwegi... Mail from the UK; and Aftenposten, Dagbladet, and...
Breaking Biology News(10 mins):Goulbourne earns NSF award to research heart stent sensors 2Goulbourne earns NSF award to research heart stent sensors 3Molecular evolution is echoed in bat ears 2Atomic structure of the mammalian 'fatty acid factory' determined 2Atomic structure of the mammalian 'fatty acid factory' determined 3What is a gene? 2Children with healthier diets do better in school 14827 1Aflac Named Among the 50 Best Companies for Supplier Diversity 14824 1Aflac Named Among the 50 Best Companies for Supplier Diversity 14824 2Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem Cell Therapy for Brain Cancer 4110 1Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem Cell Therapy for Brain Cancer 4110 2Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem Cell Therapy for Brain Cancer 4110 3Tiny buckyballs squeeze hydrogen like giant Jupiter 2561 1Tiny buckyballs squeeze hydrogen like giant Jupiter 2561 2
...tend to avoid human contact. But recently, coyotes...eastern United States, including southeastern New ...nge of urban and suburban areas. , "This kind of a...e coyotes actually start attacking humans -- such ...s as a potential food source," says Paul Curtis, a...
...ational Laboratories has completed a two-year stud...accidental exposure to depleted uranium (DU) durin...Uranium Dispersal and Health Effects Using a Gulf ...Marshall, employs analytical capabilities used by ...examines health risks associated with uranium hand...
...University researchers have revealed a process tha...ow an acid derived from vitamin A enters a cell,s ...ects. , Discovery of this basic transport mechani... compounds. The finding has important implications..., The research, which appears in a recent issue of...
...he reasons HIV is so difficult to contain and trea...efenses and viral countermeasures contribute to th...oteins that mutate HIV DNA and interfere with the ...rotein, called Vif, that can disable the two defen...n sequence and in function, according to a new stu...
Other Biology News:Why are coyotes getting more aggressive? 2Sandia completes depleted uranium study 2Study shows how retinoic acid enters a cell's nucleus 2Study shows how retinoic acid enters a cell's nucleus 3
...utilizes a silica based spin filter membrane to is..., the desired DNA band is cut from an agarose gel ...el slice is melted irreversibly in a high molarity...ica spin filter membrane and washed once to remove...
Mouse monoclonal antibody to CDC2L5 - cell division cycle 2-like 5 (cholinesterase-related cell division controller)
GenomePlex Whole Genome Amplification (WGA) kit from Sigma-Aldrich
...s Transfer Vector is a derivative of the pAcHLT-A ... blue fluorescent protein (BFP), followed by a 6xH...genes are expressed as BFP-6xHis fusion proteins w...nzyme,sites (EcoR I, Stu I, Sac I, Not I, Pst I, K...
Biology Products: